Showing results (381-390 of 1,561) with videos related to
Sort By:
Pageof 157
Expert Review of Hematology|November 18, 2024
BCL-2 inhibition in acute myeloid leukemia: resistance and combinationsQi Zhang Tatarata, Zhe Wang, Marina KonoplevaExpert Review of Hematology|November 12, 2024
Current and emerging therapies as potential treatment for people with von Willebrand diseaseEmmanuel J Favaloro, Leonardo Pasalic, Jennifer CurnowExpert Review of Hematology|November 4, 2024
Identification of miR-451 target genes as prognostic markers in diffuse large B-cell lymphomaYi Zhang, Zichen Wei, Han Xu, et al.Expert Review of Hematology|October 4, 2025
Stem cell boost for immune effector cell associated hematotoxicity in multiple myeloma: minimizing long-term complications and expanding post CAR T-cell therapy relapse optionsMeera Mohan, Carolina SchinkeExpert Review of Hematology|September 29, 2025
Safety and efficacy of non-first-line drugs in the treatment of immune thrombocytopenia: a systematic review and network meta-analysisXin Zhou, Mengran Li, Xiaohui Sui, et al.Expert Review of Hematology|January 11, 2020
Is outcome of older people with acute myeloid leukemia improving with new therapeutic approaches and stem cell transplantation?Felicetto Ferrara, Alessandra PicardiExpert Review of Hematology|October 30, 2019
Management of age-associated medical complications in patients with β-thalassemiaIrene Motta, Marta Mancarella, Alessia Marcon, et al.Expert Review of Hematology|September 25, 2020
An evaluation of ticagrelor for the treatment of sickle cell anemiaJaime Ribeiro-Filho, Sètondji Cocou Modeste Alexandre Yahouédéhou, Thassila Nogueira Pitanga, et al.Expert Review of Hematology|October 5, 2020
Developing strategies to reduce the duration of therapy for patients with myeloproliferative neoplasmsMichal Bar-Natan, Ronald HoffmanExpert Review of Hematology|April 7, 2020
Cost-effectiveness of once weekly carfilzomib 70 mg/m2 plus dexamethasone in patients with relapsed and refractory multiple myeloma in the United StatesShaji K Kumar, Istvan Majer, Sumeet Panjabi, et al.Pageof 157